OFF-LABEL AND UNLICENSED PRESCRIBING IN PAEDIATRIC OUTPATIENTS WITH NEPHROTIC SYNDROME: AN INDONESIAN CONTEXT
DI-018
ECULIZUMAB IN THE ATYPICAL HAEMOLYTIC URAEMIC SYNDROME: A CASE REPORT
DI-011
BOTULINUM TOXIN TYPE A OPTIMISATION
DI-090
CONDITIONS OF USE AND TOLERANCE OF TRAMADOL IN THE HOSPITALIZED ELDERLY
DI-056
LINEZOLID INDUCED THROMBOCYTOPENIA IN A PATIENT WITH RENAL INSUFFICIENCY: A CASE REPORT AND A RETROSPECTIVE CASE STUDY
CP-081
NUTRITIONAL SCREENING IN ONCOLOGY OUTPATIENS TREATED WITH ORAL ANTINEOPLASTIC DRUGS IN A PHARMACEUTICAL CARE CONSULTATION
DI-089
NEW APPROACH TO THE MANAGEMENT OF THE HEREDITARY FRUCTOSE INTOLERANCE HYPOGLYCAEMIA: TREATMENT WITH ORAL MANNOSE
DI-088
EVEROLIMUS IN TUBEROUS SCLEROSIS COMPLEX TREATMENT
DI-087
OVERUSE OF VITAMIN K-DEPENDENT CLOTTING FACTORS AND CORRECTIVE ACTIONS
DI-086
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY ASSOCIATED WITH FINGOLIMOB USE IN A PATIENT WITH MULTIPLE SCLEROSIS WITHOUT PREVIOUS EXPOSURE TO IMMUNOSUPRESSANT DRUGS
DI-082
ADVERSE EVENTS OF PIRFENIDONE AND CAUSE OF SUSPENSION IN CLINICAL PRACTICE
DI-081
EFFECTIVENESS AND SAFETY OF PIRFENIDONE IN THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
DI-080
SUCCESSFUL TREATMENT AND PREVENTION OF CISPLATIN/ETOPOSIDE INDUCED ENCEPHALOPATHY WITH THIAMINE
DI-079
DEVELOPING A TEST BATTERY FOR PEOPLE’S HAND-EYE FUNCTION IN RELATION TO TABLET SUBDIVISION
